MGCD-265 analog
Product Specifications
CAS Number
875337-44-3
Target
Apoptosis, VEGFR, c-Met/HGFR
Related Pathways
Apoptosis, Angiogenesis, Tyrosine Kinase/Adaptors
Purity
0.9921
Bioactivity
MGCD-265 analog (Glesatinib) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
Smiles
Cn1cnc(c1)-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1
Molecular Formula
C26H20FN5O2S2
Molecular Weight
517.6
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15145789 1 Vial
Lentiviral mouse Opn1mw shRNA (UAS) - Lentiviral mouse Opn1mw shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details A01331-2-APC 100 µg/Vial
Anti-CIT Antibody Picoband® APC Conjugated
Sign In for Pricing
View Details 
GTR15328903 1 Vial
Lentiviral human SLC52A1 shRNA (UAS) - Lentiviral human SLC52A1 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details